The mean level of CCL18 in the serum samples from carcinoma patients (n = 170) was 150(857) ng/ml, which was significantly higher than the control samples (n = 31, 32(61) ng/ml; p<0.0001). The gene discussed is CCL18; the disease is carcinoma.